Synonym: 4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid
CAS Number: 215307-86-1
Empirical Formula (Hill Notation): C21H21NO4
Molecular Weight: 351.40
MDL Number: MFCD18384955
Linear Formula: C21H21NO4
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML0286-5MG.
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C21H21NO4/c1-20(2)15-10-7-13(11-16(15)21(3,4)19(20)26)17(23)22-14-8-5-12(6-9-14)18(24)25/h5-11H,1-4H3,(H,22,23)(H,24,25) |
| InChI key |
KFBPBWUZXBYJDG-UHFFFAOYSA-N |
| Quality Level |
100  |
| SMILES string |
CC1(C)C(=O)C(C)(C)c2cc(ccc12)C(=O)Nc3ccc(cc3)C(O)=O |
| solubility |
DMSO: ≥5 mg/mL |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
BMS 753 is a very potent, specific agonist for RARa (Ki = 2 nM). |
| Biochem/physiol Actions: |
BMS 753 is a very potent, specific agonist for RARa (Ki = 2 nM). BMS 753 does not display significant effects on RARg in reporter based assays, or in binding assays measuring displacement of labeled retinoic acid. |
| Features and Benefits: |
This compound is featured on the Nuclear Receptors (Non-Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: |
5, 25 mg in glass bottle |
| Symbol |
GHS07 |
| Signal word |
Warning |
| Hazard statements |
H302 |
| Hazard Codes |
Xn |
| Risk Statements |
22 |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |